Table 3.
Corpus cavernosum electromyography findings (VAD: Vasoactive-drug (Papaverine 60 mg.), SD: Standard deviation).
| Group 1 (n = 9) | Group 2 (n = 10) | Group 3 (n = 10) | p | |
|---|---|---|---|---|
| Pre-VAD inj. amplitude, mean ± SD (μV) | 233,33 ± 69,10 | 166,00 ± 43,25 | 255,00 ± 57,20 | 0,005* |
| Pre-VAD inj. frequency per min, mean ± SD | 4,22 ± 0,36 | 3,70 ± 0,36 | 4,80 ± 0,41 | 0,162 |
| Post-VAD inj. amplitude, mean ± SD (μV) | 113,33 ± 25,00 | 123,00 ± 26,26 | 101,00 ± 23,23 | 0,150 |
| Post-VAD inj. frequency per min, mean ± SD, | 2,77 ± 0,22 | 2,60 ± 0,16 | 3,20 ± 0,32 | 0,344 |
| Relaxation Degree, mean ± SD | 0,41 ± 0,07 | 0,32 ± 0,06 | 0,58 ± 0,04 | 0,009** |
Group1-Group2 p:0,042; Group1-Group3 p:0,690; Group2-Group3 p:0,005 (Mann Whitney U)
Group1-Group2 p:0,065; Group1-Group3 p:0,278; Group2-Group3 p:0,002 (Mann Whitney U)